/
PFE
$24.86-$0.24 (-0.95%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
3
institutions
Market cap
$142.0B
5,699M shares
52-week range
$23.11 – $28.75
31% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
CS
Change$-19.05
Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
www.pfizer.com- Employees
- 75,000
- IPO / List date
- Jun 22, 1951
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds PFE.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Scion Asset ManagementCALLas of 2025-09-30 | 6,000,000 | $152.9M |
| Renaissance Technologiesas of 2025-09-30 | 3,395,558 | $86.5M |
Dividend history
TTM yield · 6.92% ($1.72/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-24 | $0.4300 | 2026-09-01 |
| 2026-05-08 | $0.4300 | 2026-06-12 |
| 2026-01-23 | $0.4300 | 2026-03-06 |
| 2025-11-07 | $0.4300 | 2025-12-01 |
| 2025-07-25 | $0.4300 | 2025-09-02 |
| 2025-05-09 | $0.4300 | 2025-06-13 |
| 2025-01-24 | $0.4300 | 2025-03-07 |
| 2024-11-08 | $0.4200 | 2024-12-02 |
| 2024-07-26 | $0.4200 | 2024-09-03 |
| 2024-05-09 | $0.4200 | 2024-06-14 |
Recent trades on TradeandTell
- 7/10/2026in July Portfolio →
- 7/10/2026in July Portfolio →
